Tin tức & Cập nhật

While tolvaptan does not seem to provide a clear economic benefit in all patients with chronic heart failure (CHF), its use in those who require high-dose furosemide may be cost-effective, a recent study has found.

Sacubitril/valsartan performs comparably as enalapril or valsartan alone in preventing atrial fibrillation (AF) occurrence in patients with heart failure (HF), reports a recent meta-analysis.